EBOLA SCOURGE MAY BENEFIT MEDIGARD

Written on the 28 November 2014 by Nick Nichols

EBOLA SCOURGE MAY BENEFIT MEDIGARD

THE Ebola scourge could spell good news for Gold Coast company Medigard (ASX: MGZ) as its blood collection device finally hits the market.

The fledgling medical instruments developer says sales of the device are expected to start in March with the product gaining exposure in the global medical industry after featuring in the 2014 Sol Millennium Catalogue.

Medigard last year secured an exclusive licence agreement with Shanghai Sol-Millennium Medical Products Co to manufacture and distribute its Blood Collection Device and Blood Flash Needle.

Medigard chairman Don Channer told the company’s annual general meeting this week that shareholders and directors “look forward to the rewards” ahead thanks to next year’s sales launch of the device.

He says feedback from the Blood Collection Device’s recent showing at the Medica trade fair in Germany had been “positive”.

“Our aspirations of being cheapest and best are being satisfied,” Channer says.

“All manufacturing machinery has been modified for the change in materials and samples of the new device are being circulated in selected locations in the US, UK and hopefully soon Brazil.

“Although it has taken us very much longer than expected to arrive at this position, our experience and success in the evolution of the Blood Collection Device has provided a clear pathway for the commercialisation of future products.”

Medigard says the Blood Collection Device has patents in Australia, the US, Japan, Canada and Europe, while the 3ml vacuum retractable syringe has patents in South Africa, the US, Australia, China, Japan and Canada.

“The Blood Flash Needle which will be the next focus for the company and Sol Millennium has granted patents in Australia, South Africa and Europe,” says Channer.

“With the incidence of such terrible epidemics as Ebola, the need for safety medical devices is increasing.

“We believe the company and Sol Millennium will be well placed to help satisfy this need.”


Author: Nick Nichols

Latest News

PROFIT BOOST FORECAST AT VILLA WORLD

VILLA World has forecast profit growth of 5 per cent in the first half of FY17 in an earnings guidance released to th...

WP CURVE SOLD TO GODADDY

NASDAQ-listed tech company GoDaddy has bought Gold Coast's WP Curve for an undisclosed sum.

The subscription-b...

BOARD SHAKE-UP TAKES OUT SURFSTITCH FOUNDER

ONLINE actionwear retailer SurfStitch Group (ASX: SRF) has announced a major board shake-up in a move that effectivel...

ORIGIN TO DIVEST UPSTREAM OIL AND GAS BUSINESS

ORIGIN Energy will spin off its upstream oil and gas business in an as-yet unpriced IPO.

It will allow the Sydney-...

Related News

HOW MCDONALD'S AUSTRALIA REDISCOVERED ITS INNOVATIVE SPIRIT

MCDONALD'S is such a ubiquitous part of the Australian landscape today that it is easy to forget how it change...

JB HI-FI IS THE GOOD GUY IN $870 MILLION ACQUISITION

ELECTRONICS giant JB Hi-Fi has formally completed its $870 million acquisition of home appliance chain The Good Gu...

ACCC ACTS AGAINST MERITON'S RIGGED REVIEWS

MERITON Property Services is under fire from Australia's main consumer watchdog, after it allegedly engaged in mi...

ACCC FIRES WARNING SHOT TO IVF PROVIDERS

IVF clinics have been put on notice by consumer watchdog, the Australian Competition and Consumer Commission (ACCC...

Contact us

Email News Update Sign Up Contact Details

Subscribe to our mailing list

* indicates required
Email Format

PO Box 2087
Brisbane QLD 4001

LoginTell a FriendSign Up to Newsletter